As of my last knowledge update in October 2023, "hMAO-B-IN-7" with the CAS number "2955577-14-5" is a chemical compound that serves as an inhibitor of the enzyme monoamine oxidase B (MAO-B). This enzyme is involved in the metabolism of neurotransmitters such as dopamine, and its inhibition can have implications in the treatment of neurodegenerative diseases like Parkinson's disease. hMAO-B-IN-7 is characterized by its specific binding affinity to the MAO-B enzyme, which can lead to increased levels of dopamine in the brain, potentially alleviating symptoms associated with dopamine deficiency. The compound's structure typically includes functional groups that facilitate its interaction with the enzyme's active site. Additionally, studies may explore its pharmacokinetics, efficacy, and safety profile in various biological systems. However, detailed information regarding its physical properties, such as solubility, melting point, and stability, may require further investigation or specific literature references. Always consult scientific databases or literature for the most current and detailed information.

hMAO-B-IN-7

2955577-14-5: As of my last knowledge update in October 2023, "hMAO-B-IN-7" with the CAS number "2955577-14-5" is a chemical compound that serves as an inhibitor of the enzyme monoamine oxidase B (MAO-B). This enzyme is involved in the metabolism of neurotransmitters such as dopamine, and its inhibition can have implications in the treatment of neurodegenerative diseases like Parkinson's disease. hMAO-B-IN-7 is characterized by its specific binding affinity to the MAO-B enzyme, which can lead to increased levels of dopamine in the brain, potentially alleviating symptoms associated with dopamine deficiency. The compound's structure typically includes functional groups that facilitate its interaction with the enzyme's active site. Additionally, studies may explore its pharmacokinetics, efficacy, and safety profile in various biological systems. However, detailed information regarding its physical properties, such as solubility, melting point, and stability, may require further investigation or specific literature references. Always consult scientific databases or literature for the most current and detailed information.

Compound 11n (hMAO-B-IN-7) is a potent inhibitor of human monoamine oxidase-B (hMAO-B) that can cross the blood-brain barrier (BBB). It demonstrates an IC 50 value of 0.79±0.05 μM and is useful in research related to Alzheimer's disease (AD) and Parkinson's disease (PD) [1].

CAS 2955577-14-5

hMAO-B-IN-7

hMAO-B-IN-7

Ref: TM-T86586